Imaging findings and progress in treatment of small cell lung cancer
XIAO Yongxin
LIU Shiyuan
Abstract：Small cell lung cancer (SCLC) is the most common primary neuroendocrine malignancy of the lung and is characterized by a rapid doubling time, easy metastasis in early stage and poor prognosis. CT is the most commonly examination method. Familiar with the CT features of SCLC is essential. MRI can better show the brain metastasis of SCLC. DWI can provide molecular level information in the diagnosis and differential diagnosis of SCLC. PET/CT is more accurate than CT in the clinical staging of SCLC, and it is better to evaluate the therapeutic effect and prognosis. The main treatment of SCLC is radiotherapy and chemotherapy. Surgery should be considered in patients with stageⅠ(T1-2, N0), can improve the survival rate of patients. In this paper we reviewed imaging findings and progress in treatment of SCLC.
Keywords：Small cell lung cancerTomographyX-ray computedemission computedMagnetic resonance imagingTreatment
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 152-156 )